22nd Century to Participate in the HC Wainwright Conference in New York City September 9, 2025

Rhea-AI Summary

22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference. The company's leadership, including CEO Larry Firestone and CFO Dan Otto, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel.

Interested investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations directly.

News Market Reaction – XXII

-5.26%

-5.26% Session close to close

In the Sep 8 session, XXII declined 5.26%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MOCKSVILLE, N.C., Sept. 05, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced that Larry Firestone, Chief Executive Officer, and Dan Otto, Chief Financial Officer, will host investor meetings on Tuesday, September 9, 2025 as part of the HC Wainwright Conference taking place at the Lotte New York Palace Hotel.

Investors can register and request meetings via their HC Wainwright representative or 22nd Century Investor Relations at mkreps@xxiicentury.com.

About 22nd Century Group, Inc.

22nd Century Group is pioneering the nicotine harm reduction movement in the tobacco industry enabling smokers to take control of their nicotine consumption.

We created our flagship product, the VLN^® cigarette, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN^® cigarettes have 95% less nicotine than the traditional cigarette and have been proven to allow consumers to greatly reduce their nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers in the form that they are used to, the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether.

Our proprietary non-GMO reduced nicotine tobacco blends are made possible by comprehensive and patented technologies and tobacco plants that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets.

VLN^® is a registered trademark of 22nd Century Limited LLC.

Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.

Learn more about VLN^® at tryvln.com.

Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200

FAQ

When is 22nd Century Group (XXII) presenting at the HC Wainwright Conference 2025?

22nd Century Group will host investor meetings on Tuesday, September 9, 2025 at the Lotte New York Palace Hotel.

Who will represent 22nd Century Group (XXII) at the HC Wainwright Conference?

CEO Larry Firestone and CFO Dan Otto will represent the company at the conference.

How can investors schedule meetings with 22nd Century Group (XXII) management at the conference?

Investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations at mkreps@xxiicentury.com.

What is 22nd Century Group's (XXII) main business focus?

22nd Century Group is a tobacco products company that has spent 27 years leading efforts to combat smoking harms driven by nicotine addiction.